Diaceutics PLC (DXRX) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.07x
Diaceutics PLC (DXRX) has a Cash Flow Reinvestment Rate of 0.07x as of June 2025, reinvesting GBX55.00K (capex GBX55.00K ) from operating cash flow of GBX800.00K. Explore Diaceutics PLC (DXRX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.07x
(Capex + Investments) / Operating CF
Total Reinvested
GBX55.00K
Capex + Investments
Operating Cash Flow
GBX800.00K
GBX
Capital Expenditures
GBX55.00K
GBX
Diaceutics PLC Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Diaceutics PLC across 7 annual periods. Also explore Diaceutics PLC total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Diaceutics PLC (2016–2024)
Year-by-year capital reinvestment analysis for Diaceutics PLC. For live market cap and broader valuation context, see DXRX market cap.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 13.31x | GBX8.66 Million | GBX651.00K | GBX4.63 Million | ▲ +92.5% |
| 2023 | 6.91x | GBX9.06 Million | GBX1.31 Million | GBX4.86 Million | ▲ +265.9% |
| 2022 | 1.89x | GBX9.63 Million | GBX5.10 Million | GBX4.87 Million | ▼ -90.4% |
| 2021 | 19.65x | GBX11.20 Million | GBX570.00K | GBX5.60 Million | ▼ -60.5% |
| 2020 | 49.75x | GBX12.59 Million | GBX253.00K | GBX6.29 Million | ▲ +13390.3% |
| 2017 | 0.37x | GBX565.83K | GBX1.53 Million | GBX282.92K | ▲ +328.4% |
| 2016 | 0.09x | GBX58.03K | GBX674.01K | GBX29.03K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow